| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jeannine Lynch | VP of Market Access Strategy | 2025-09-02 | 1,591 | $0.64 | $1.02kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Lind Global Fund II LP | 565.20% | 15,906,941 | $114.69M | Insider |
| Timwell Corp Ltd | 142.13% | 4,000,000 | $28.84M | Insider |
| Yaskawa Electric Corp | 55.50% | 1,561,968 | $11.26M | Insider |
| Oramed Pharmaceuticals Inc | 44.43% | 1,250,363 | $9.02M | Insider |
| Scp Vitalife Partners II LP | 36.16% | 1,017,674 | $7.34M | Insider |
| Scp Vitalife Partners Israel II LP | 12.08% | 339,900 | $2.45M | Insider |
| Almog Adar | 9.33% | 262,500 | $1.89M | Insider |
| Ori Gon | 8.57% | 241,282 | $1.74M | Insider |
| Jeff Dykan | 8.34% | 234,812 | $1.69M | Insider |
| Charles Remsberg | 7.11% | 200,000 | $1.44M | Insider |